MediciNova, Inc. (MNOV)
Total Valuation
MediciNova has a market cap or net worth of $90.74 million. The enterprise value is $39.43 million.
| Market Cap | 90.74M |
| Enterprise Value | 39.43M |
Important Dates
The next estimated earnings date is Tuesday, December 5, 2023, after market close.
| Earnings Date | Dec 5, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding.
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 22.60% |
| Float | 42.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 90.74 |
| Forward PS | n/a |
| PB Ratio | 1.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 39.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 18.92 |
| Quick Ratio | 18.74 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.20% and return on invested capital (ROIC) is -17.09%.
| Return on Equity (ROE) | -14.20% |
| Return on Assets (ROA) | -13.50% |
| Return on Capital (ROIC) | -17.09% |
| Revenue Per Employee | $76,923 |
| Profits Per Employee | -$731,840 |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $2,822 in taxes.
| Income Tax | 2,822 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.95% in the last 52 weeks. The beta is 0.91, so MediciNova's price volatility has been similar to the market average.
| Beta (1Y) | 0.91 |
| 52-Week Price Change | -31.95% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 2.18 |
| Relative Strength Index (RSI) | 45.22 |
| Average Volume (30 Days) | 97,133 |
Short Selling Information
The latest short interest is 237,746, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 237,746 |
| Short Previous Month | 243,390 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 17.01 |
Income Statement
In the last 12 months, MediciNova had revenue of $1.00 million and -$9.51 million in losses. Loss per share was -$0.19.
| Revenue | 1.00M |
| Gross Profit | 1.00M |
| Operating Income | -11.09M |
| Pretax Income | -9.51M |
| Net Income | -9.51M |
| EBITDA | -9.30M |
| EBIT | -9.51M |
| Loss Per Share | -$0.19 |
Balance Sheet
The company has $51.51 million in cash and $205,394 in debt, giving a net cash position of $51.30 million or $1.05 per share.
| Cash & Cash Equivalents | 51.51M |
| Total Debt | 205,394 |
| Net Cash | 51.30M |
| Net Cash Per Share | $1.05 |
| Equity / Book Value | 64.67M |
| Book Value Per Share | 1.32 |
| Working Capital | 50.19M |
Cash Flow
In the last 12 months, operating cash flow was -$10.94 million and capital expenditures -$26,331, giving a free cash flow of -$10.97 million.
| Operating Cash Flow | -10.94M |
| Capital Expenditures | -26,331 |
| Free Cash Flow | -10.97M |
| FCF Per Share | -$0.22 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,108.95% and -951.39%.
| Gross Margin | 100.00% |
| Operating Margin | -1,108.95% |
| Pretax Margin | -951.11% |
| Profit Margin | -951.39% |
| EBITDA Margin | -930.22% |
| EBIT Margin | -951.11% |
| FCF Margin | -1,096.54% |
Dividends & Yields
MediciNova does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -10.49% |
| FCF Yield | -12.08% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 31, 2006. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 31, 2006 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MediciNova has an Altman Z-Score of 7.64 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.64 |
| Piotroski F-Score | 1 |